GE HealthCare said it is cooperating with reviews by the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) into potential violations of the Foreign Corrupt Practices Act (FCPA) in China.
GE HealthCare discloses FCPA reviews into China activities
